Fosamax (Alendronate) FAERS Safety Signals: Post-Market Surveillance Data and FDA Label Updates
A clinical review of alendronate (Fosamax) safety signals reported through the FDA Adverse Event Reporting System (FAERS), including atypical femoral fractures, osteonecrosis of the jaw, and esophageal events.
Read clinical review